MedPath

E-health treatment in dialysis

Conditions
End-stage renal disease (ESRD), dialysis, health-related quality of life (HRQOL), E-health, Online CBT, tailored care
Registration Number
NL-OMON20743
Lead Sponsor
eiden University
Brief Summary

n/a

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
130
Inclusion Criteria

1. end-stage renal disease (GFR <15 ml/min/1.73 m2)

2. treated for at least 3 months by means of dialysis (hemodialysis or peritoneal dialysis)

Exclusion Criteria

1. serious medical conditions that are likely to interfere with completion of the study (such as progressive malignancy or other debilitating illness) at the discretion of the nephrologist

2. a life expectancy < 12 months after the start of the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary study outcome is distress, as measured by a combination of anxiety (GAD-7) and depression (PHQ-9).
Secondary Outcome Measures
NameTimeMethod
1. change in disease-specific self-efficacy and self-management.<br /><br>2. meaningful improvements on the areas of interest to the patients (using a personalized outcome measure).<br>
© Copyright 2025. All Rights Reserved by MedPath